MAM
McLean Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,770
| Closed | -$541K | – | 164 |
|
|
2025
Q1 | $541K | Buy |
24,770
+15,972
| +182% | +$349K | 0.18% | 70 |
|
|
2024
Q4 | $233K | Sell |
8,798
-312
| -3% | -$8.28K | 0.07% | 138 |
|
|
2024
Q3 | $260K | Buy |
9,110
+119
| +1% | +$3.4K | 0.08% | 134 |
|
|
2024
Q2 | $255K | Sell |
8,991
-1,203
| -12% | -$34.1K | 0.08% | 126 |
|
|
2024
Q1 | $273K | Sell |
10,194
-1,984
| -16% | -$53.1K | 0.09% | 119 |
|
|
2023
Q4 | $359K | Sell |
12,178
-593
| -5% | -$17.5K | 0.13% | 83 |
|
|
2023
Q3 | $424K | Sell |
12,771
-96
| -0.7% | -$3.18K | 0.17% | 69 |
|
|
2023
Q2 | $472K | Buy |
12,867
+114
| +0.9% | +$4.18K | 0.19% | 64 |
|
|
2023
Q1 | $520K | Sell |
12,753
-801
| -6% | -$32.7K | 0.21% | 56 |
|
|
2022
Q4 | $695K | Sell |
13,554
-33
| -0.2% | -$1.69K | 0.24% | 53 |
|
|
2022
Q3 | $575K | Sell |
13,587
-71
| -0.5% | -$3.01K | 0.22% | 50 |
|
|
2022
Q2 | $720K | Buy |
13,658
+70
| +0.5% | +$3.69K | 0.29% | 40 |
|
|
2022
Q1 | $703K | Buy |
13,588
+7
| +0.1% | +$362 | 0.52% | 37 |
|
|
2021
Q4 | $769K | Buy |
13,581
+358
| +3% | +$20.3K | 0.3% | 38 |
|
|
2021
Q3 | $576K | Buy |
13,223
+2,813
| +27% | +$123K | 0.22% | 48 |
|
|
2021
Q2 | $420K | Buy |
10,410
+100
| +1% | +$4.04K | 0.19% | 55 |
|
|
2021
Q1 | $396K | Sell |
10,310
-126
| -1% | -$4.84K | 0.31% | 53 |
|
|
2020
Q4 | $384K | Buy |
+10,436
| New | +$384K | 0.34% | 47 |
|